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clusion: A nutritional intervention based on circulating IgG 
antibodies against food antigens showed effects with re-
spect to stool frequency. The mechanisms by which IgG an-
tibodies might contribute to disease activity remain to be 
elucidated.  Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 Genetic influences  [1, 2] , cytokine activation  [3] and 
various specific and nonspecific environmental factors 
like hygiene, social standard, climatic factors, environ-
mental pollution, smoking, stress and nutrition  [4–7] 
have been considered to be associated with the induction 
and/or exacerbation of inflammatory bowel disease 
(IBD), such as Crohn’s disease (CD).
 Serologic markers for IBD, like anti- Saccharomyces 
cerevisiae antibodies and atypical perinuclear antineu-
trophil cytoplasmic antibodies, remain to play a role in 
the pathophysiology of IBD. There is a wide range of 
 other antibodies including outer-membrane porin C, 
anti- Pseudomonas fluorescens and antiglycan antibodies 
(anti-laminaribioside carbohydrate antibody, anti-chito-
bioside carbohydrate antibody, anti-mannobioside car-
bohydrate antibody), and anti-CBir1. The latter is the 
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 Abstract 
 Background: Environmental factors are thought to play an 
important role in the development of Crohn’s disease (CD). 
Immune responses against auto-antigens or food antigens 
may be a reason for the perpetuation of inflammation.  Meth-
ods: In a pilot study, 79 CD patients and 20 healthy controls 
were examined for food immunoglobulin G (IgG). There-
after, the clinical relevance of these food IgG antibodies
was assessed in a double-blind cross-over study with 40 pa-
tients. Based on the IgG antibodies, a nutritional interven-
tion was planned. The interferon (IFN)  secretion of T cells 
was measured. Eosinophil-derived neurotoxin was quanti-
fied in stool.  Results: The pilot study resulted in a significant 
difference of IgG antibodies in serum between CD patients 
and healthy controls. In 84 and 83% of the patients, respec-
tively, IgG antibodies against processed cheese and yeast 
were detected. The daily stool frequency significantly de-
creased by 11% during a specific diet compared with a sham 
diet. Abdominal pain reduced and general well-being im-
proved. IFN  secretion of T cells increased. No difference for 
eosinophil-derived neurotoxin in stool was detected.  Con-
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first bacterial antigen found to induce colitis in animal 
models of IBD and also leads to a pathological immune 
response in IBD patients  [8] .
 Frequently, IBD patients report that dietary intoler-
ance significantly contributes to their symptomatology. 
The benefit from eliminating certain foods  [9] from dai-
ly diet was refocused in the present study. Attempts to test 
for food intolerance in IBD have largely focused on classic 
food allergies based on the presence of immunoglobulin 
E (IgE)-mediated antibody responses, although these re-
actions appear probably quite rare in IBD  [10] . It is there-
fore possible that adverse reactions in IBD might be due 
to some reactions mediated by IgG antibodies, which 
characteristically give a more delayed response following 
exposure to a particular antigen  [11] and have been im-
plicated in some cases of food hypersensitivity  [12–14] . 
However, this mechanism is controversial and is consid-
ered to be physiological  [15–17] , as IgG food antibodies 
can be present in apparently healthy individuals  [18, 19] . 
It has been assumed that chronic inflammation in IBD is 
due to an imbalance between inflammatory and anti-in-
flammatory mechanisms like regulatory CD4+CD25+ T 
cells (T regs )  [20–22] .
 High IgG levels against certain food components in 
blood and the inflammatory response of T cells to food 
antigens and the regulatory effect of T regs in vitro was as-
sessed. As IgG food antibodies may play a role during the 
initiation or perpetuation of IBD, we first investigated the 
presence of IgG antibodies in CD patients and healthy 
controls. In a second approach, the therapeutic potential 
of an elimination diet based on the presence of IgG anti-
bodies to food in patients with CD in a randomized con-
trolled trial was investigated. Primary outcome parame-
ters were stool frequency, abdominal pain and general 
well-being. The possible activation of T-effector cells 
through IgG antibodies was measured by interferon 
(IFN)  secretion. For the evaluation of disease activity, 
eosinophil-derived neurotoxin (EDN) was quantified in 
stool. A secondary outcome parameter was the total score 
built from stool frequency, abdominal pain and general 
well-being.
 Methods 
 Study Design 1: Pilot Study 
 Initially, 20 healthy volunteers without history of food intoler-
ance and 79 CD patients with different disease status were in-
cluded in a pilot study. Forty-seven of them had clinical and en-
doscopic signs of acute inflammation (i.e. diarrhea and mucosal 
ulcerations). Twenty-four CD patients presented with chronically 
active disease and 8 were in remission. Patients were recruited 
from the German IBD Competence Network serum bank and ex-
amined for food specific IgG by the ImuPro300 test (Evomed, 
Darmstadt, Germany). Disease activity was assessed by the pa-
tient’s medical record.
 Study Design 2: Following Intervention Study 
 Consecutively in a randomized, double-blind, cross-over in-
tervention study, the clinical relevance of IgG antibodies against 
food antigens in 40 CD patients was tested. Not all patients from 
the previous pilot study were willing to participate in the follow-
ing intervention study; therefore, new patients were also tested for 
food IgG antibodies in serum. Patients were not selected for IgG 
levels in serum. A sample size calculation was not performed. Fi-
nally, the specific antibody pattern of 40 patients was determined 
in serum samples by the ImuPro300 test system. The reactivity of 
T regs and CD4+CD25– T cells to the patient-specific food antigens 
was determined in vitro (mixed lymphocyte stimulation assay) 
and correlated with in vivo  changes on the basis of a nutritional 
record and a patient diary. The diary contained questions about 
stool frequency, abdominal pain and general well-being. Patients 
validated their pain perception with scores of 0, 1, 2 and 3 which 
represented no pain, slight pain, moderate pain and severe pain, 
respectively. The values were accumulated after each week. Ad-
ditionally, the patients rated their general well-being. The patients 
assessed general well-being by a score of 0, 1, 2, 3 and 4, which 
represented good, worse, bad, very bad and terrible, respectively. 
To get an overall impression of the symptoms, stool frequency, 
abdominal pain and general well-being, a total score was calcu-
lated. Each subject recorded his eating habits and disease symp-
toms over a period of 12 weeks and followed a specific or sham 
diet. Each diet was followed for 6 weeks ( fig. 1 ). The definition of 
specific and sham diet was based on similarity of excluded food 
components. If, for example, IgG against hazelnut was detected, 
then almond was excluded in the sham diet; if cauliflower IgG was 
found, broccoli was excluded. Patients were concealed and allo-
cated to one of the two diet sheets based on a randomization 
schedule using a random computer number generator. Thus, pa-
tients received either an elimination diet based on their true sen-
sitivity results (specific diet) or a sham diet. Baseline demograph-
ic and clinical characteristics of the two groups, including the use 
of concomitant medication, were found to be similar. All patients 
and clinical staff in the gastroenterology research department 
were blinded to the group assignment of all patients for the dura-
tion of the study. Patients were given their allocated diet sheet by 
staff at the gastroenterology department and asked to eliminate 
the indicated foods from their diet for a period of 12 weeks. They 
also received a booklet with advice on how to eliminate the dif-
ferent foods (recipes and menus). This was explained by an expe-
rienced nutritionist. Furthermore, the telephone contact details 
of a free nutritional advisor who they could contact for further 
advice if necessary was given to each patient.
 Subjects 
 There were 16 male and 24 female subjects. Ultimately, data 
analysis of 23 patients was performed. Patients between the ages 
of 18 and 60 years were considered eligible. In this study, the pa-
tients were between 21 and 59 (mean 41  8 11) years of age. Both 
active and inactive patients were included, and diagnosis was 
manifested at least 6 months before onset of the trial. Duration of 
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disease was between 2 and 39 years (mean 14.9  8 10.6). Patients 
were excluded from participating if they had any significant co-
existing disease. During screening some patients had to be ex-
cluded due to a lack of cooperation (n = 3), severe concomitant 
disease (n = 10), abscesses (n = 15) or for C-reactive protein  1 150 
(n = 4). Twenty-eight of the patients refused to participate. During 
the intervention phases the patients were allowed to take con-
comitant medication provided it had been constant for the 12 
weeks of intervention ( table 1 ). The constant medication over 
time was requested to determine a specific effect of nutritional 
intervention and not of higher doses of medication. This study 
was approved by the ethics committee of the University of Re-
gensburg and performed according to the declaration of Helsinki. 
Informed consent was obtained from all patients.
Consort Flowchart
Assessed for eligibility from the
German IBD Competence Network,
Ratisbona, Germany (n = 100) 
Excluded (n = 60)
Not meeting inclusion criteria
(n = 32)
Refused to participate
(n = 28)
Analyzed (n = 12)
Excluded from analysis (n = 0)
Allocated to intervention 1 (specific diet, 6 weeks)
(n = 20)
Received allocated intervention
(n = 20)
Did not receive allocated intervention
(n = 0) 
Analyzed (n = 11)
Excluded from analysis (n = 0)
Allocation 
Analysis 
Enrollment 
Randomized (n = 40)
Allocated to intervention 2 (sham diet, 6 weeks)
(n = 20)
Received allocated intervention
(n = 20)
Did not receive allocated intervention
(n = 0) 
Allocated to intervention 1 (specific diet, 6 weeks)
(n = 20)
Received allocated intervention
(n = 11)
Did not receive allocated intervention
(n = 9)
Reasons
diet too restrictive: 6
low compliance: 1
other reasons: 2 
Allocated to intervention 2 (sham diet, 6 weeks)
(n = 20)
Received allocated intervention
(n = 12)
Did not receive allocated intervention
(n = 8)
Reasons
diet too restrictive: 4
low compliance: 2
other reasons: 2  
 Fig. 1. Study flow of the intervention trial. Patients were allocated to one of the two diets: either an elimination 
diet based on their true sensitivity results (specific diet) or a sham diet and followed for 6 weeks. 17 patients did 
not finish the trial. 
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 ImuPro300 Test 
 Sera from 40 patients was examined for food specific IgG by 
an enzyme-linked immunosorbent assay (ELISA) ImuPro300 test 
according to the manufacturer’s recommendations (R-Biopharm, 
Darmstadt, Germany). Specific IgG antibodies against 271 food 
allergens (online suppl. table 1, for all online suppl. material see 
www.karger.com/doi/10.1159/000264649) are possible to deter-
mine in human serum. The content of IgG antibodies is demon-
strated in  table 2 . Only high values (score 3) and very high values 
(score 4) of IgG were excluded from the diet of the patients. Di-
luted human serum was incubated in three different 96-well 
plates, each well coated with a different food extract. After wash-
ing the plates 3 times with diluted washing buffer, a polyclonal 
anti-human IgG antibody (sheep; R-Biopharm) conjugated to al-
kaline phosphatase was added. After washing with phosphate-
buffered saline (PBS), substrate solution (pnpp, R-Biopharm) was 
Table 1. Baseline characteristics of the patients: 16 males (m) and 24 females (w) participated in the study
No. Gender Age Disease localization Treatment
1 m 21 terminal ileum, cecum mesalazine, dimeticone, diltiazem
2 w 55 cecum to sigma azathioprine, glibenclamide
3 w 24 colon, terminal ileum budesonide
4 w 37 terminal ileum, cecum budesonide, azathioprine, mesalazine, hydro-
cortisonacetate, loperamide
5 m 37 terminal ileum, proximal colon, proctitis azathioprine, prednisolone
6 m 44 terminal ileum, cecum azathioprine, prednisolone
7 m 41 ileum resection, multiple perianal fistulae mesalazine
8 w 37 anastomosis budesonide
9 m 37 distal ileum azathioprine
10 m 27 terminal ileum, cecum azathioprine
11 m 54 neoterminal ileum, colon, sigma, anal stenosis cholestyramine
12 m 55 terminal ileum azathioprine
13 w 31 esophagus lesions infliximab, azathioprine, prednisolone
14 m 54 stenosis terminal ileum, ileocecal resection none
15 w 57 sigma segment resection, stenosis colon descendens cholestyramine
16 w 38 colon, sigma, rectum, stenosis terminal ileum mesalazine, azathioprine, hydrocortisone
17 w 43 terminal ileum azathioprine, azulfidine
18 w 54 colon infliximab
19 w 54 colon azathioprine
20 w 31 neoterminal ileum, colon 6-mercaptopurine
21 w 50 fistulae azathioprine
22 w 33 neoterminal ileum infliximab
23 w 25 colon, distal ileum mesalazine
24 w 46 terminal ileum, caecum, sigma, rectum budesonide, azathioprine
25 w 49 ileotransversostomy azathioprine 
26 w 57 fistulae infliximab, azathioprine, azulfidine, mesalazine, 
cholestyramine
27 m 41 colon prednisolone, azathioprine
28 w 48 colon, ileocecal resection methotrexate
29 m 51 colon budesonide
30 m 35 rectum azathioprine, loperamide
31 m 29 colon prednisolone, mesalazine, hydrocortisone
32 w 59 colon, neoterminal ileum azathioprine
33 w 43 terminal ileum, colon mesalazine
34 w 48 neoterminal ileum budesonide
35 m 42 rectum, sigma, fistulae prednisolone, ciprofloxacine, metronidazole
36 w 22 terminal ileum, colon cholestyramine
37 w 28 colon infliximab
38 w 44 terminal ileum, sigma methotrexate, azathioprine
39 m 41 terminal ileum, colon infliximab
40 m 35 colon azathioprine
Patients were between 21 and 59 years of age (42 8 12), treated with diverse drugs (treatment) and had different disease localization.
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added to reveal the presence of IgG in the serum. Color develop-
ment is proportional to the quantity of bound antibodies. After 
addition of a stop solution (NaOH; R-Biopharm), optical densities 
were measured photometrically (405/620 nm, Tecan Sunrise; Te-
can GmbH, Crailsheim, Germany). IgG concentrations were cal-
culated using a standard curve.
 Collection of Peripheral Blood and Isolation of T regs and 
CD4+CD25– T Cells 
 50 ml of peripheral blood were obtained from each patient at 
the beginning of the trial and after 6 and 12 weeks. Blood was di-
luted with RPMI 1640 (Sigma-Aldrich Chemie, Steinheim, Ger-
many) in a ratio of 1: 2. Peripheral blood mononuclear cells 
(PBMCs) were isolated from the diluted blood by lymphocyte sep-
aration medium (PAA Laboratories GmbH, Pasching, Austria). 
20 ml of lymphocyte separation medium were carefully covered 
with a layer of diluted blood and centrifuged at 400  g for 20 min 
at room temperature.
 CD4+ T cells were isolated from PBMC using AutoMACS 
(Miltenyi Biotec, Bergisch Gladbach, Germany) with a CD4+
 CD25+ Regulatory T Cell Isolation Kit (Miltenyi Biotec) follow-
ing the manufacturer’s instructions. 0.4–1  ! 10 6 T regs were iso-
lated from 50 ml with the AutoMACS programs Depl05 and Pos-
seld2. Normally, T regs make up to 0.7–5.5% of PBMCs and 5–10% 
of T-helper cells  [20, 23, 24] . CD4– cells in the remaining negative 
fraction were used to isolate antigen presenting cells (APC). CD4– 
cells were allowed to adhere to 96-well tissue culture plates (Fal-
con, Becton Dickinson, Heidelberg, Germany) for 2 h in an incu-
bator at 37 ° C, 5% CO 2 (Heraeus 6000, Sepatech, Osterode, Ger-
many). Nonadherent cells were removed by washing the wells 
repeatedly with prewarmed RPMI 1640. Adherent cells were used 
as APC.
 Assay of Suppressor Function by T regs 
 For suppression assays, 0.5–1  ! 10 5 CD4+CD25– T cells were 
cultured in the absence or presence of 0.5–1  ! 10 5 autologous 
T regs /well in 96-well plates and in the presence of 2  ! 10 5 adher-
ent APC in RPMI 1640 medium with 1% nonessential amino ac-
ids (100 ! ) and 1 m M sodium pyruvate (PAA Laboratories GmbH, 
Pasching, Austria), 1% MEM vitamins (100 ! ; Biochrom, Berlin, 
Germany), 25,000 U penicillin and 25 mg streptomycin (Gibco 
BRL Life Technologies, Eggenstein, Germany),   -mercaptoetha-
nol (final concentration 3  ! 10 –5  M ; Gibco, Invitrogen, Karlsruhe, 
Germany), and 10% AB-serum (Cambrex Corporation, Europe). 
Cells were stimulated with food antigens (20   g/ml; HAL Allergie 
GmbH, Düsseldorf, Germany), negative control solution (diluent 
without antigen, HAL Allergie GmbH) or Dynabeads  CD3/
CD28 T Cell Expander (Dynal  , Hamburg, Germany). These an-
tigen solutions (as well as negative control solution) are common-
ly used for prick test analysis as previously described by Van Den 
Bogaerde  [25] . The cells were cultured at 37 ° C, 5% CO 2 for 24 and 
72 h, respectively.
 Fluorescence-Activated Cell Sorting (FACS) 
 To determine the purity of the isolated T cell fractions, cells 
were stained with CD25-PE and CD4-FITC. The following anti-
bodies were used: 10   l of anti-human CD4-FITC, clone M-T466, 
isotype mouse IgG1 and 10   l anti-human CD25-PE, clone 7D4, 
isotype mouse IgG2b (Miltenyi Biotec) according to the manufac-
turer’s instructions. The antibodies were incubated for 15 min on 
ice and washed twice with PBS (PAA Laboratories GmbH). Sub-
sequently, the cells were fixed with 3.7% paraformaldehyde, cen-
trifuged at 300  g for 5 min and resuspended in 100   l of PBS.
 Stimulation of T cells with food antigens results in cell divi-
sion with distinct fluorescence peaks, allowing determination of 
the number of cell divisions calculated by carboxyfluorescein di-
acetate succinimidyl ester (CFSE) fluorescence (Sigma-Aldrich 
Chemie, Taufkirchen, Germany). CFSE is a fluorescein derivative 
which passively diffuses through the cell membrane and binds 
irreversibly to cytoplasmatic proteins. 24 and 72 h after in vitro 
stimulation, cells were analyzed by FACS. Proliferation is shown 
as a decrement of fluorescence because CFSE is distributed among 
the daughter cells. The cells were examined with an EPICS XL-
MCL (Coulter Immunotech, Hamburg, Germany).
 Determination of IFN  
 IFN  secretion in cell supernatants was quantitatively mea-
sured by ELISA (IFN  -ELISA Set; Biosciences, San Diego, Calif., 
USA) according to the manufacturer’s protocol.
 Determination of EDN 
 For the evaluation of a potential food allergy and disease activ-
ity, EDN was detected in 80 g of stool by ELISA (Immundiagnos-
tik, Bensheim, Germany) according to the manufacturer’s proto-
col.
 Data Analysis 
 Statistical analysis was carried out using SPSS, R and Sigma 
Stat. Weekly counts of stool frequency were analyzed with Pois-
son regression using generalized estimating equations (GEEs, 
 [26] ) to account for correlations between observations made from 
the same individual. This method provides a robust standard er-
ror for the treatment effect which was used to calculate confi-
dence intervals and p values. Tests for cross-over effects were also 
performed by GEEs. Moreover, GEEs with normal outcomes have 
been used to analyze the total score. Data were not analyzed ac-
cording to the intention-to-treat principle.
 The application of all tests was verified by normality tests 
(Kolmogorov-Smirnov test, Shapiro-Wilk test). For statistical 
analysis of the pilot study, the quantity of patients and healthy 
controls with IgG antibody levels (in percent) was assessed by a t 
test. Statistical analysis of IFN  secretion was performed by the 
Table 2. IgG antibodies in patients’ serum by ImuPro300
IgG-class Allergen-specific
IgG content
<7.49 g/ml 0 (0.0–0.9) negative
7.5–12.49 g/ml 1 (1.0–1.9) weak
12.5–19.99 g/ml 2 (2.0–2.9) increased
20.0–49.99 g/ml 3 (3.0–3.9) high
≥50 g/ml 4 (4.0–4.9) very high
In patient-specific diets, only foods with score 3 (IgG content 
20–49.49 g/ml) and score 4 (IgG content ≥50 g/ml) were ex-
cluded.
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Kruskal-Wallis test based on non-normally distributed data. Val-
ues were significantly different when the obtained difference in 
mean ranks was greater than the   2 value (in all figures indicated 
with #). Values are expressed as the mean [minimum, maximum]. 
Statistical analysis of EDN in stool was performed by analysis of 
variance (ANOVA) for normally distributed data. Statistical sig-
nificance was based on a p value smaller than 0.05.
 Results 
 Pilot Study-IgG Antibodies in CD Patients and 
Healthy Controls 
 The pilot study resulted in a significant difference of 
IgG antibodies in serum between CD patients and healthy 
controls (p  ! 0.0001, t test). All detected IgG antibody 
reactions are presented online (online suppl. table 2). The 
ten most frequently measured IgG antibodies in CD pa-
tients were against processed cheese (84%), yeast (83%), 
agave syrup (78%), camembert cheese (76%), poppy seeds 
(74%), aloe vera (74%), bamboo sprouts (73%), kamut (du-
rum wheat, 70%), unripe spelt grain (69%) and wheat 
(60%). More CD patients showed reactions against the 
evaluated food components than healthy controls, i.e. 
35% of healthy controls had IgG antibodies against wheat 
in contrast to 60% of CD patients. Moreover, 39% of CD 
patients had IgG antibodies against hazelnut in contrast 
to only 15% of healthy controls. This was even more pro-
nounced in IgG antibodies against linseed, where 70% of 
CD patients and only 10% of healthy controls showed IgG 
antibodies. The same was seen with processed cheese 
(60% of healthy controls vs. 84% of CD patients).
 The most frequently detected IgG antibodies in healthy 
controls were against yeast (66%),  Aspergillus niger  (60%), 
whey (60%), processed cheese (60%), bamboo sprouts 
(55%), paprika spice (55%), crawfish meat (50%), cottage 
cheese (45%), yoghurt (45%) and zander (45%).
 Effects of the Nutritional Intervention on Stool 
Frequency, Abdominal Pain and General Well-Being 
 There was no evidence for a cross-over effect in the 
analysis of the weekly stool frequency counts (p = 0.08). 
In the specific diet group, a significant reduction in the 
daily stool frequency by 11% was achieved compared to 
the sham diet group (p = 0.004, 95% CI: 4%, 18%). How-
ever, the effect was confounded by a significant increase 
in stool frequency of 9% in the second intervention phase 
of the study, regardless of type of diet (p = 0.025, 95% CI: 
1%, 18%;  fig. 2 ). The comparison of loose stools during 
the specific and sham diets of each patient demonstrated 
that, surprisingly, only those patients who first followed 
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 Fig. 2. Progression of stool frequency. Stool frequency was moni-
tored per week. Only those patients who first followed the spe-
cific diet had a significant reduction in stool frequency. Subjects 
who first followed the sham diet had no significant change in their 
stool frequency (GEE analysis). 
 Fig. 3. Progression of total score. An average reduction of the total 
weekly score of 6.5 points was estimated for the specific diet group 
compared with the sham diet group (GEE analysis). 
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the specific diet had a significant reduction in stool fre-
quency. The group of subjects who first followed the sham 
diet and then specific diet had no significant change in 
their stool frequency. 
 Patients were asked to rate their pain perception and 
general well-being. The given points were accumulated 
after each week. To obtain an overall impression of stool 
frequency, abdominal pain and general well-being, a total 
score was calculated. There was neither evidence for a 
cross-over effect nor an intervention phase in the analysis 
of the total score. An average reduction of the total week-
ly score ( fig. 3 ) of 6.5 points was estimated for the spe-
cific diet group compared with the sham diet group (95% 
CI: –0.6, 13.6 points). The estimated effect seems to have 
a clinically relevant effect, but is not significant (p = 
0.07).
 IFN  Secretion of CD4+CD25– Effector T Cells and 
T regs 
 Isolation of CD4+CD25– effector T cells and T regs was 
controlled by FACS analysis. The purity of CD4+CD25– 
effector T cells was 90.8 and 62.6% for T regs ( fig. 4 a, b). 
CD4+CD25– effector T cells and APC were incubated in 
the absence or presence of T regs and stimulated with food 
antigens, negative control solution or antiCD3/antiCD28 
solution. The effect of food antigens on CD4+CD25– T 
cell activation was evaluated by quantification of IFN  in 
cell supernatants by ELISA ( fig. 5–7 ). All obtained IFN  
values were not normally distributed; therefore, a Krus-
kal-Wallis test was performed.
 Stimulation of CD4+CD25– and APC with Food 
Antigens and Negative Control Solution 
 The incubation of CD4+CD25– T cells and APC with 
food antigens caused an increase in IFN  secretion ( fig. 5 , 
left panel). The amount of IFN  at base value (time point 
zero) was 170.5 pg/ml [16.5; 495.3] and increased during 
specific diet (411.1 pg/ml [16.9; 1,117.0]) and sham diet 
(481.5 pg/ml [1.5; 1,234.0]). Unfortunately, there was no 
significant difference between the three time points.
 Stimulation of CD4+CD25– T cells and APC with 
negative control solution ( fig. 5 , right panel) showed
IFN  secretion comparable to food antigen solution. The 
amount of IFN  at base value was 153.1 pg/ml [5.8; 587.6] 
and increased during specific diet (308.3 pg/ml [61.0; 
1,220.0]) and sham diet (681.6 pg/ml [126.0; 1,347.0]). 
There was a significantly higher IFN  secretion during 
sham diet than during specific diet or base value, when 
cells were stimulated by negative control solution.
 In summary, CD4+CD25– T cells were not clearly 
more stimulated by food antigen solution than by nega-
tive control solution. 
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and APC in the presence of T regs with food 
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Comparison of IFN  secretion (pg/ml) be-
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tion), specific diet and sham diet (after 6 
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ulation with food antigens (left panel): 
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 Stimulation of the Co-Culture of CD4+CD25–, APC 
and T regs with Food Antigens and Negative Control Solu-
tion 
 The co-culture of CD4+CD25– T cells and APC with 
T regs and stimulation with food antigens ( fig. 6 , left panel) 
also resulted in an increase in IFN  secretion from base 
value (169.5 pg/ml [42.7; 543.1]) to specific diet (683.8
pg/ml [37.4; 1,311.0]) or sham diet (609.8 pg/ml [34.0; 
1,209.0]). Unfortunately, there was no significant differ-
ence between the three time points.
 There was lower IFN  secretion when co-cultivated 
CD4+CD25– T cells, APC and T regs were stimulated with 
negative control solution ( fig. 6 , right panel). Significant-
ly lower IFN  secretion was only received between base 
value (294.4 pg/ml [10.1; 1,587.0]) and sham diet (21.2 pg/
ml [1.9; 53.8]). Specific diet (71.6 pg/ml [2.9; 231.4]) re-
sulted in no significant difference.
 In summary, there was no clear difference between
the culture of CD4+CD25– T cells and the culture of 
CD4+CD25– T cells with T regs .
 Stimulation with AntiCD3/AntiCD28 Solution 
 The stimulation with antiCD3/antiCD28 beads of 
CD4+CD25– T cells and APC, or the co-cultivation of 
CD4+CD25– T cells, APC and T regs ( fig. 7 ) showed high-
er IFN  secretion in contrast to the stimulation with food 
antigens or negative control solution. Therefore, cells 
were more effectively stimulated with antiCD3/antiCD28 
solution than with food antigen/negative control solu-
tion, as seen in 1,000-fold higher IFN  secretion.
 In case of CD4+CD25– T cells ( fig. 7 , left panel), a sig-
nificant increase in IFN  secretion was detected between 
base value (48.2 ng/ml [0.8; 151.0]) and specific diet (169.3 
ng/ml [19.6; 307.0]). There was no significant difference 
between base value and sham diet (204.6 ng/ml [12.10; 
791.0]).
 The mixture of CD4+CD25– T cells, APC and T regs 
( fig. 7 ,  right panel) showed only a significant increase be-
tween base value (51.9 ng/ml [0.1; 271.0]) and sham diet 
(135.9 ng/ml [49.20; 309.0]). The increase during specific 
diet (157.9 ng/ml [26.20; 621.0]) was not significant.
 In summary, none of the three different stimulation 
methods led to a significant difference in IFN  secretion 
of CD4+CD25– T cells or the mixture of CD4+CD25– T 
cells and T regs .
 Time Course of Cell Division after Cell Stimulation 
 The proliferative response of the isolated T lympho-
cytes to stimulation with food antigens, negative control 
solution and antiCD3/antiCD28 solution was investigated 
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APC and T regs with antiCD3/antiCD28 so-
lution. Comparison of IFN  secretion (ng/
ml) between base value (beginning of in-
tervention), specific diet and sham diet 
(after 6 weeks of intervention, respective-
ly). There was 1,000-fold higher IFN  se-
cretion when cells were stimulated with 
antiCD3/antiCD28 solution than with 
food antigen/negative control solution. 
There was higher IFN  secretion of 
CD4+CD25– T cells (left panel) between 
base value and specific diet. The mixture 
of CD4+CD25– T cells, APC and T regs 
showed a significant increase only between 
base value and the sham diet. Kruskal-
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er than the   2 value); uindicates outliers. 
 Food Antigens in Crohn’s Disease Digestion 2010;81:252–264 261
by CFSE ( fig. 8 ,  9 ). Each of the curves reflects a measure-
ment of the fluorescence intensity caused by cell division. 
CD4+CD25– T cells and APC in the absence or presence 
of T regs did not demonstrate any in vitro proliferative re-
sponses to food antigens. Hence, the isolated T cells do not 
proliferate in vitro after stimulation with food antigens.
 Quantification of EDN in Stool 
 The disease activity was evaluated by the quantifica-
tion of EDN in stool samples ( fig. 10 ). The samples were 
normally distributed and, therefore, ANOVA was per-
formed. The concentration of EDN at the beginning of 
intervention (base value) was 1,536  8 405 ng/ml. The 
concentration declined during specific diet (1,228  8 530 
ng/ml) but also during sham diet (1,355  8 373 ng/ml). 
There was no significant difference between the three 
time points. EDN concentration dropped in the same de-
gree under specific diet and sham diet. No difference for 
EDN in stool indicated an absence of eosinophil-medi-
ated reactions.
 Discussion 
 In the present study, we have shown that IgG antibod-
ies against food antigens are elevated in patients with CD 
in contrast to healthy controls. A clinically significant 
improvement in IBD symptoms was observed in patients 
eliminating foods to which they were found to exhibit 
sensitivity. IFN  secretion by T cells was increased after 
specific diet, but also after sham diet. There was a reduc-
tion of EDN concentration in stool during specific diet 
and sham diet, but no significant difference between the 
two diets.
 Forty-eight percent of patients in the present interven-
tion study had an improvement in stool frequency and 
general well-being (total score). Only 9% of patients de-
scribed opposite effects.
 The study results are encouraging; however, they have 
to be interpreted with care as results may have been in-
fluenced by several confounders: The daily reporting of 
consumed foods and the attachment to the diet recom-
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 Fig. 8. CFSE proliferation in the mixture of CD4+CD25– T cells, 
APC and T regs measured by FACS analysis. CD4+CD25– T cells 
and APC in the presence of T regs did not demonstrate any in vitro 
proliferative responses to food antigens. After 24 h: stimulation 
with food antigens (red), negative control solution (green) and 
antiCD3/antiCD28 solution (blue); after 72 h: stimulation with 
food antigens (orange), negative control solution (purple) and an-
tiCD3/antiCD28 solution (black); graphs were recorded separate-
ly and are shown in overlay mode. 
 Fig. 9. CFSE proliferation of CD4+CD25– T cells and APC mea-
sured by FACS analysis. CD4+CD25– T cells and APC in the 
 absence of T regs did not demonstrate any in vitro proliferative 
 responses to food antigens. After 24 h: stimulation with food
antigens (red), negative control solution (green) and antiCD3/ 
antiCD28 solution (blue); after 72 h: stimulation with food anti-
gens (orange), negative control solution (purple) and antiCD3/ 
antiCD28 solution (black). Graphs were recorded separately and 
are shown in overlay mode. 
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mendations required much time and discipline from the 
study subjects. Therefore, the problem of under-report-
ing (consumed foods and beverages were not listed cor-
rectly) is evident. We tried to reduce this problem by ex-
plaining the list of foods to be avoided in great detail to 
each patient and showing ‘hidden sources’. This was done 
by one well-trained person.
 Basically, the main limitation of this cross-over study 
was the high dropout rate (n = 17), which was a result of 
the length of the study, the changes in CD and voluntary 
withdrawals.
 In addition, the 40 patients initially included in this 
study were on different medications. Due to low numbers 
of individuals in this study, stratification according to the 
different treatments would have caused inability to do a 
statistical analysis. However, strong immunosuppres-
sants certainly could have influenced the study results, 
especially with respect to T cell function. We tried to re-
duce this problem by keeping the medication constant for 
the time of intervention. In addition, many of the patients 
with CD already kept to some individual forms of diet, 
avoiding bloating foods such as onions or garlic  [27–30] .
 In addition, it may be argued that the sham diet was 
too similar to the specific diet, as the definition of spe-
cific and sham diet was based on the similarity of exclud-
ed food components. If for example IgG against hazelnut 
was detected, then almond was excluded in the sham diet; 
if cauliflower IgG was found, broccoli was excluded. 
There may be some cross-reactivity of the respective an-
tigens, which could explain some effects of the sham diet 
on IBD symptoms, T cell cytokine secretion and stool 
EDN levels.
 In addition, we did not have a washout phase at the 
cross-over point, which may have led to some transmis-
sion of effects into the sham arm of the study.
 More than 80% of CD patients in the pilot study and 
more than 30% of CD patients in the intervention study 
had IgG antibodies against yeast. The IgG-antibody
reactions against food antigens were also investigated in 
CD patients by Van Den Bogaerde  [25] . Increased sensi-
tization against yeast was demonstrated in vivo and in 
vitro as in the present study. Additionally, a study from 
Darroch et al.  [31] pointed out that antibodies against 
 Saccharomyces cerivisiae are significantly increased in 
patients with CD in comparison to patients with ulcer-
ative colitis and that they play a role in the function of T 
and B cells in patients with CD. In the present study, the 
difference in T cell function is shown by higher IFN  se-
cretion. Elevated IFN  levels after nutritional interven-
tion were detected in supernatants of cultures of 
CD4+CD25– T cells and APC in the presence or absence 
of T regs . The mucosa of CD patients is dominated by T 
cells of the T-helper cell phenotype 1  [32] .
 These cells are characterized by the secretion of IFN  . 
A greater number of cells secreting IFN  in CD in con-
trast to ulcerative colitis and healthy controls was found 
 [33] . IFN  is involved in specific cell-mediated immunity 
and causes the secretion of IgG2 antibodies during de-
layed-type hypersensitivity. Van Den Bogaerde et al.  [25] 
illustrated, both in vitro and in vivo, a more pronounced 
reaction of T cells against food antigens. They tested the 
proliferation of peripheral blood lymphocytes after stim-
ulation with different food antigens like cereal, cabbage, 
citrus fruits, yeast and nuts in 10 CD patients and 10 
healthy controls  [25] . They used commercial prick solu-
tion (just like in the present study) for cell stimulation. 
The authors concluded that in vivo sensitization against 
food antigens exists. The mechanism has to be further 
elucidated, perhaps due to a defective epithelial barrier 
function, which might allow infiltration of food antigens 
to the mucosa. IFN  secretion of T regs after stimulation 
with antiCD3/antiCD28 solution was also analyzed by 
Earle et al.  [34] . In this issue, T regs secreted no IFN  in 
contrast to PBMC which secreted a concentration of 500 
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 Fig. 10. Detection of EDN in stool samples. Comparison between 
base value (beginning of intervention), specific diet and sham diet 
(after 6 weeks of intervention, respectively). EDN concentration 
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